NOTICE: Scitation Maintenance Sunday, March 1, 2015.

Scitation users may experience brief connectivity issues on Sunday, March 1, 2015 between 12:00 AM and 7:00 AM EST due to planned network maintenance.

Thank you for your patience during this process.

banner image
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.
The importance of adaptive response in cancer prevention and therapy
Rent this article for
Access full text Article
1. J. Folkman, “Anti-angiogenesis: New concept for therapy of solid tumors,” Ann. Surg. 175, 409416 (1972).
2. K. J. Kim, B. Li, J. Winer, M. Armanini, N. Gillett, H. S. Phillips, and N. Ferrara, “Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo,” Nature (London) 362, 841844 (1993).
3. M. Paez-Ribes, E. Allen, J. Hudock, T. Takeda, H. Okuyama, F. Vinals, M. Inoue, G. Bergers, D. Hanahan, and O. Casanovas, “Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis,” Cancer Cells 15, 220231 (2009).
4. F. Azam, S. Mehta, and A. L. Harris, “Mechanisms of resistance to antiangiogenesis therapy,” Eur. J. Cancer 46, 13231332 (2010).
5. J. M. Ebos and R. S. Kerbel, “Antiangiogenic therapy: Impact on invasion, disease progression, and metastasis,” Nat. Rev. Clin. Oncol. 8, 210221 (2011).
6. F. Shojaei, “Anti-angiogenesis therapy in cancer: Current challenges and future perspectives,” Cancer Lett. 320, 130137 (2012).
7. N. T. Fernando, M. Koch, C. Rothrock, L. K. Gollogly, P. A. D’Amore, S. Ryeom, and S. S. Yoon, “Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors,” Clin. Cancer Res. 14, 15291539 (2008).
8. K. Okuma, H. Yamashita, Y. Niibe, K. Hayakawa, and K. Nakagawa, “Abscopal effect of radiation on lung metastases of hepatocellular carcinoma: A case report,” J. Med. Case Rep. 5, 111 (2011).
9. S. Demaria, B. Ng, M. L. Devitt, J. S. Babb, N. Kawashima, L. Liebes, and S. C. Formenti, “Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated,” Int. J. Radiat. Oncol., Biol., Phys. 58, 862870 (2004).
10. E. F. Stamell, J. D. Wolchok, S. Gnjatic, N. Y. Lee, and I. Brownell, “The abscopal effect associated with a systemic anti-melanoma immune response,” Int. J. Radiat. Oncol., Biol., Phys. (in press).
11. S. E. Cotter, G. P. Dunn, K. M. Collins, D. Sahni, K. A. Zukotynski, J. L. Hansen, D. A. O’Farrell, A. K. Ng, P. M. Devlin, and L. C. Wang, “Abscopal effect in a patient with metastatic Merkel cell carcinoma following radiation therapy: Potential role of induced antitumor immunity,” Arch. Dermatol. 147, 870872 (2011).
12. P. B. Lakshmanagowda, L. Viswanath, N. Thimmaiah, L. Dasappa, S. S. Supe, and P. Kallur, “Abscopal effect in a patient with chronic lymphocytic leukemia during radiation therapy: A case report,” Cases J. 2, 204 (2009).
13. M. Nakanishi, M. Chuma, S. Hige, and M. Asaka, “Abscopal effect on hepatocellular carcinoma,” Am. J. Gastroenterol. 103, 13201321 (2008).
14. V. Celer, “Suppressive effects of ionizing radiation on immunoproductive cells in laboratory mice,” Vet. Med. (Praha) 35, 495500 (1990).
15. Y. Ina, H. Tanooka, T. Yamada, and K. Sakai, “Suppression of thymic lymphoma induction by life-long low-dose-rate irradiation accompanied by immune activation in C57BL/6 mice,” Radiat. Res. 163, 153158 (2005).
16. K. Sakamoto, “Radiobiological basis for cancer therapy by total or half-body irradiation,” Nonlinearity Biol. Toxicol. Med. 2, 293316 (2004).
17. M. Z. Dewan, A. E. Galloway, N. Kawashima, J. K. Dewyngaert, J. S. Babb, S. C. Formenti, and S. Demaria, “Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody,” Clin. Cancer Res. 15, 53795388 (2009).
18. N. Wu, S. Z. Jin, X. N. Pan, and S. Z. Liu, “Increase in efficacy of cancer radiotherapy by combination with whole-body low dose irradiation,” Int. J. Radiat. Biol. 84, 201210 (2008).
19. J. R. Cameron, “A prospective study should be performed to test the hypothesis that an increase in background radiation to residents in the gulf states will increase their longevity. For the proposition,” Med. Phys. 29, 15111512 (2002).
20. T. D. Luckey, “Nurture with ionizing radiation: A provocative hypothesis,” Nutr. Cancer 34, 111 (1999).
21. Z. Jaworowski, “The paradigm that failed,” Int. J. Low Radiat. 5, 151155 (2008).
22. B. R. Scott, “It's time for a new low-dose-radiation risk assessment paradigm–One that acknowledges hormesis,” Dose Response 6, 333351 (2008).
23. M. Doss, “Shifting the paradigm in radiation safety,” Dose Response 10, 562583, (2012).

Data & Media loading...


Article metrics loading...



There is no abstract available for this article.


Full text loading...

This is a required field
Please enter a valid email address
752b84549af89a08dbdd7fdb8b9568b5 journal.articlezxybnytfddd
Scitation: The importance of adaptive response in cancer prevention and therapy